CDK1 and cancer: Overexpression of CDK1 has been found to be a biomarker in a number of different types of cancer, including lung, pancreas and sarcomas (M. Li et al., 2020; Q. Li, Zhang, et al., 2019; Piao et al., 2019; Yamamura et al., 2020).